Related Experiment Video
Updated: Apr 6, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A
Mingchen Shao1, Yiwei Geng1, Peng Lu2
1Oncology Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Laboratory of Tumor Biology, Zhengzhou University, Zhengzhou, China.
Abstract:
MicroRNAs (miRNAs) play important roles in the pathogenesis of many types of cancers by negatively regulating gene expression at posttranscriptional level. However, the role of microRNAs in anaplastic thyroid carcinoma (ATC), has remained elusive. Here, we identified that miR-4295 promotes ATC cell proliferation by negatively regulates its target gene CDKN1A. In ATC cell lines, CCK-8 proliferation assay indicated that the cell proliferation was promoted by miR-4295, while miR-4295 inhibitor significantly inhibited the cell proliferation. Transwell assay showed that miR-4295 mimics significantly promoted the migration and invasion of ATC cells, whereas miR-4295 inhibitors significantly reduced cell migration and invasion. luciferase assays confirmed that miR-4295 directly bound to the 3'untranslated region of CDKN1A, and western blotting showed that miR-4295 suppressed the expression of CDKN1A at the protein levels. This study indicated that miR-4295 negatively regulates CDKN1A and promotes proliferation and invasion of ATC cell lines. Thus, miR-4295 may represent a potential therapeutic target for ATC intervention.
Insights
MicroRNAs (miRNAs) promote anaplastic thyroid carcinoma (ATC) cell growth and invasion by targeting CDKN1A. Inhibiting miR-4295 could be a therapeutic strategy for ATC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression implicated in cancer.
- The specific role of miRNAs in anaplastic thyroid carcinoma (ATC) pathogenesis is not well understood.
Purpose of the Study:
- To investigate the function of miR-4295 in anaplastic thyroid carcinoma (ATC).
- To identify the target gene of miR-4295 and its role in ATC progression.
Main Methods:
- Cell proliferation was assessed using CCK-8 assays.
- Cell migration and invasion were evaluated via Transwell assays.
- Target gene validation involved luciferase assays and Western blotting.
Main Results:
- miR-4295 overexpression promoted ATC cell proliferation, migration, and invasion.
- miR-4295 directly targeted and suppressed CDKN1A expression at the protein level.
- Inhibiting miR-4295 significantly reduced ATC cell proliferation and invasion.
Conclusions:
- miR-4295 promotes ATC progression by negatively regulating CDKN1A.
- miR-4295 represents a potential therapeutic target for anaplastic thyroid carcinoma intervention.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Inhibition of Cdk Activity
Inhibition of CDK Activity
Mitogens and the Cell Cycle
Abnormal Proliferation

